Rumi Scientific, Inc.
NY
- UEI
- Y1U1A5Y75CN7
- CAGE
- 8LQ71
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 34 35th St, Brooklyn, NY 11232, USA
- Website
- rumiscientific.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Neucyte Inc. | Mountain View, CA | 325414 Biological Product (except Diagnostic) Manufacturing |
| Stem Pharmacy | Fitchburg, WI | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| 28Bio, Inc. | Metairie, LA | 541380 Testing Laboratories and Services |
| Vala Sciences Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Lena Biosciences, Inc. | Atlanta, GA | — |
About the company
Rumi Scientific, Inc. is a self-certified small disadvantaged business and for-profit organization specializing in developing innovative platforms for drug discovery and disease modeling, particularly in the fields of neurodevelopmental disorders and infectious diseases. Registered in SAM.gov since May 20, 2020, the company has secured multiple federal grant awards to support its research and development efforts. Rumi Scientific's primary focus appears to be on creating advanced in vitro tools and platforms that mimic human tissue development and function, enabling more effective drug discovery processes and disease modeling for complex disorders such as autism spectrum disorders (ASDs) and respiratory syncytial virus (RSV) infections.
Through its federal grant awards, Rumi Scientific has undertaken several significant research projects. One major initiative, funded by a $1,006,032 grant from the National Institute of Mental Health (NIMH), involves developing an integrated drug discovery platform for ASDs using standardized self-organizing human cerebroids. This project aims to create in vitro tools to reveal monogenic ASD phenotypes at the neuronal assembly level, optimize protocols for characterizing human neuronal networks, and conduct drug discovery for ASD therapeutics. Another project, supported by the National Institute of Allergy and Infectious Diseases (NIAID), focuses on creating self-organizing synthetic human lungs on microchips to combat RSV infections. This work involves screening a large compound library to identify potential therapeutics for RSV. Additionally, Rumi Scientific has received funding from the Department of Defense's Medical Command to develop a high-throughput screening platform for fragile X syndrome, Rett syndrome, and frontotemporal degeneration using human synthetic embryos. These diverse projects demonstrate Rumi Scientific's expertise in creating advanced biological models and screening platforms for a range of neurological and infectious diseases, positioning the company as an innovative contributor to the field of drug discovery and disease modeling.
Quick answers
Is Rumi Scientific, Inc. registered in SAM.gov?
Yes. Rumi Scientific, Inc.'s SAM.gov registration is active through February 25, 2027.
What is Rumi Scientific, Inc.'s most recent federal award?
Rumi Scientific, Inc.'s most recent federal grant award is An integrated drug discovery platform for neurodevelopmental disorders using standardized self-organizing human… (R44MH136894), from National Institute of Mental Health (NIH), on May 1, 2024.
On GovTribe
See Rumi Scientific, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors